Global Non-oncology Biopharmaceuticals Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-oncology Biopharmaceuticals Market Size 2017-2028

2.1.2 Non-oncology Biopharmaceuticals Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Non-oncology Biopharmaceuticals Segment by Type

2.2.1 Biologics

2.2.2 Biosimilars

2.3 Non-oncology Biopharmaceuticals Market Size by Type

2.3.1 Non-oncology Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)

2.4 Non-oncology Biopharmaceuticals Segment by Application

2.4.1 Immunology

2.4.2 Endocrinology

2.4.3 Others

2.5 Non-oncology Biopharmaceuticals Market Size by Application

2.5.1 Non-oncology Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)

3 Non-oncology Biopharmaceuticals Market Size by Player

3.1 Non-oncology Biopharmaceuticals Market Size Market Share by Players

3.1.1 Global Non-oncology Biopharmaceuticals Revenue by Players (2020-2022)

3.1.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Players (2020-2022)

3.2 Global Non-oncology Biopharmaceuticals Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Non-oncology Biopharmaceuticals by Regions

4.1 Non-oncology Biopharmaceuticals Market Size by Regions (2017-2022)

4.2 Americas Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)

4.3 APAC Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)

4.4 Europe Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)

4.5 Middle East & Africa Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)

5 Americas

5.1 Americas Non-oncology Biopharmaceuticals Market Size by Country (2017-2022)

5.2 Americas Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)

5.3 Americas Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-oncology Biopharmaceuticals Market Size by Region (2017-2022)

6.2 APAC Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)

6.3 APAC Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Non-oncology Biopharmaceuticals by Country (2017-2022)

7.2 Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)

7.3 Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-oncology Biopharmaceuticals by Region (2017-2022)

8.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)

8.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Non-oncology Biopharmaceuticals Market Forecast

10.1 Global Non-oncology Biopharmaceuticals Forecast by Regions (2023-2028)

10.1.1 Global Non-oncology Biopharmaceuticals Forecast by Regions (2023-2028)

10.1.2 Americas Non-oncology Biopharmaceuticals Forecast

10.1.3 APAC Non-oncology Biopharmaceuticals Forecast

10.1.4 Europe Non-oncology Biopharmaceuticals Forecast

10.1.5 Middle East & Africa Non-oncology Biopharmaceuticals Forecast

10.2 Americas Non-oncology Biopharmaceuticals Forecast by Country (2023-2028)

10.2.1 United States Non-oncology Biopharmaceuticals Market Forecast

10.2.2 Canada Non-oncology Biopharmaceuticals Market Forecast

10.2.3 Mexico Non-oncology Biopharmaceuticals Market Forecast

10.2.4 Brazil Non-oncology Biopharmaceuticals Market Forecast

10.3 APAC Non-oncology Biopharmaceuticals Forecast by Region (2023-2028)

10.3.1 China Non-oncology Biopharmaceuticals Market Forecast

10.3.2 Japan Non-oncology Biopharmaceuticals Market Forecast

10.3.3 Korea Non-oncology Biopharmaceuticals Market Forecast

10.3.4 Southeast Asia Non-oncology Biopharmaceuticals Market Forecast

10.3.5 India Non-oncology Biopharmaceuticals Market Forecast

10.3.6 Australia Non-oncology Biopharmaceuticals Market Forecast

10.4 Europe Non-oncology Biopharmaceuticals Forecast by Country (2023-2028)

10.4.1 Germany Non-oncology Biopharmaceuticals Market Forecast

10.4.2 France Non-oncology Biopharmaceuticals Market Forecast

10.4.3 UK Non-oncology Biopharmaceuticals Market Forecast

10.4.4 Italy Non-oncology Biopharmaceuticals Market Forecast

10.4.5 Russia Non-oncology Biopharmaceuticals Market Forecast

10.5 Middle East & Africa Non-oncology Biopharmaceuticals Forecast by Region (2023-2028)

10.5.1 Egypt Non-oncology Biopharmaceuticals Market Forecast

10.5.2 South Africa Non-oncology Biopharmaceuticals Market Forecast

10.5.3 Israel Non-oncology Biopharmaceuticals Market Forecast

10.5.4 Turkey Non-oncology Biopharmaceuticals Market Forecast

10.5.5 GCC Countries Non-oncology Biopharmaceuticals Market Forecast

10.6 Global Non-oncology Biopharmaceuticals Forecast by Type (2023-2028)

10.7 Global Non-oncology Biopharmaceuticals Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Non-oncology Biopharmaceuticals Product Offered

11.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Sanofi

11.2.1 Sanofi Company Information

11.2.2 Sanofi Non-oncology Biopharmaceuticals Product Offered

11.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sanofi Main Business Overview

11.2.5 Sanofi Latest Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Information

11.3.2 Johnson & Johnson Non-oncology Biopharmaceuticals Product Offered

11.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Johnson & Johnson Main Business Overview

11.3.5 Johnson & Johnson Latest Developments

11.4 Pfizer

11.4.1 Pfizer Company Information

11.4.2 Pfizer Non-oncology Biopharmaceuticals Product Offered

11.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Pfizer Main Business Overview

11.4.5 Pfizer Latest Developments

11.5 Novo Nordisk

11.5.1 Novo Nordisk Company Information

11.5.2 Novo Nordisk Non-oncology Biopharmaceuticals Product Offered

11.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Novo Nordisk Main Business Overview

11.5.5 Novo Nordisk Latest Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis Non-oncology Biopharmaceuticals Product Offered

11.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Novartis Main Business Overview

11.6.5 Novartis Latest Developments

11.7 Merck

11.7.1 Merck Company Information

11.7.2 Merck Non-oncology Biopharmaceuticals Product Offered

11.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Merck Main Business Overview

11.7.5 Merck Latest Developments

11.8 Teva

11.8.1 Teva Company Information

11.8.2 Teva Non-oncology Biopharmaceuticals Product Offered

11.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Teva Main Business Overview

11.8.5 Teva Latest Developments

11.9 Eli Lilly

11.9.1 Eli Lilly Company Information

11.9.2 Eli Lilly Non-oncology Biopharmaceuticals Product Offered

11.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Eli Lilly Main Business Overview

11.9.5 Eli Lilly Latest Developments

11.10 Bristol-Myers Squibb

11.10.1 Bristol-Myers Squibb Company Information

11.10.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Offered

11.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Bristol-Myers Squibb Main Business Overview

11.10.5 Bristol-Myers Squibb Latest Developments

11.11 GlaxoSmithKline

11.11.1 GlaxoSmithKline Company Information

11.11.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Offered

11.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 GlaxoSmithKline Main Business Overview

11.11.5 GlaxoSmithKline Latest Developments

11.12 UCB Pharma

11.12.1 UCB Pharma Company Information

11.12.2 UCB Pharma Non-oncology Biopharmaceuticals Product Offered

11.12.3 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 UCB Pharma Main Business Overview

11.12.5 UCB Pharma Latest Developments

11.13 Amgen

11.13.1 Amgen Company Information

11.13.2 Amgen Non-oncology Biopharmaceuticals Product Offered

11.13.3 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Amgen Main Business Overview

11.13.5 Amgen Latest Developments

11.14 AbbVie

11.14.1 AbbVie Company Information

11.14.2 AbbVie Non-oncology Biopharmaceuticals Product Offered

11.14.3 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 AbbVie Main Business Overview

11.14.5 AbbVie Latest Developments

11.15 Takeda

11.15.1 Takeda Company Information

11.15.2 Takeda Non-oncology Biopharmaceuticals Product Offered

11.15.3 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Takeda Main Business Overview

11.15.5 Takeda Latest Developments

11.16 AstraZeneca

11.16.1 AstraZeneca Company Information

11.16.2 AstraZeneca Non-oncology Biopharmaceuticals Product Offered

11.16.3 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 AstraZeneca Main Business Overview

11.16.5 AstraZeneca Latest Developments

11.17 Mylan

11.17.1 Mylan Company Information

11.17.2 Mylan Non-oncology Biopharmaceuticals Product Offered

11.17.3 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Mylan Main Business Overview

11.17.5 Mylan Latest Developments

11.18 LEO Pharma

11.18.1 LEO Pharma Company Information

11.18.2 LEO Pharma Non-oncology Biopharmaceuticals Product Offered

11.18.3 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 LEO Pharma Main Business Overview

11.18.5 LEO Pharma Latest Developments

11.19 Boehringer Ingelheim

11.19.1 Boehringer Ingelheim Company Information

11.19.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Offered

11.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Boehringer Ingelheim Main Business Overview

11.19.5 Boehringer Ingelheim Latest Developments

11.20 Alexion Pharmaceuticals

11.20.1 Alexion Pharmaceuticals Company Information

11.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Offered

11.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Alexion Pharmaceuticals Main Business Overview

11.20.5 Alexion Pharmaceuticals Latest Developments

11.21 Elusys Therapeutics

11.21.1 Elusys Therapeutics Company Information

11.21.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Offered

11.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Elusys Therapeutics Main Business Overview

11.21.5 Elusys Therapeutics Latest Developments

11.22 Swedish Orphan Biovitrum

11.22.1 Swedish Orphan Biovitrum Company Information

11.22.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Offered

11.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Swedish Orphan Biovitrum Main Business Overview

11.22.5 Swedish Orphan Biovitrum Latest Developments

11.23 Biogen

11.23.1 Biogen Company Information

11.23.2 Biogen Non-oncology Biopharmaceuticals Product Offered

11.23.3 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.23.4 Biogen Main Business Overview

11.23.5 Biogen Latest Developments

12 Research Findings and Conclusion

Table 1. Non-oncology Biopharmaceuticals Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Biologics

Table 3. Major Players of Biosimilars

Table 4. Non-oncology Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 7. Non-oncology Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 10. Global Non-oncology Biopharmaceuticals Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Non-oncology Biopharmaceuticals Revenue Market Share by Player (2020-2022)

Table 12. Non-oncology Biopharmaceuticals Key Players Head office and Products Offered

Table 13. Non-oncology Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Non-oncology Biopharmaceuticals Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Non-oncology Biopharmaceuticals Market Size Market Share by Regions (2017-2022)

Table 18. Americas Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Country (2017-2022)

Table 20. Americas Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 22. Americas Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 24. APAC Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Region (2017-2022)

Table 26. APAC Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 28. APAC Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 30. Europe Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Country (2017-2022)

Table 32. Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 34. Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Non-oncology Biopharmaceuticals

Table 43. Key Market Challenges & Risks of Non-oncology Biopharmaceuticals

Table 44. Key Industry Trends of Non-oncology Biopharmaceuticals

Table 45. Global Non-oncology Biopharmaceuticals Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Non-oncology Biopharmaceuticals Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Application (2023-2028)

Table 51. Roche Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 52. Roche Non-oncology Biopharmaceuticals Product Offered

Table 53. Roche Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Roche Main Business

Table 55. Roche Latest Developments

Table 56. Sanofi Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 57. Sanofi Non-oncology Biopharmaceuticals Product Offered

Table 58. Sanofi Main Business

Table 59. Sanofi Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Sanofi Latest Developments

Table 61. Johnson & Johnson Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 62. Johnson & Johnson Non-oncology Biopharmaceuticals Product Offered

Table 63. Johnson & Johnson Main Business

Table 64. Johnson & Johnson Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Johnson & Johnson Latest Developments

Table 66. Pfizer Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 67. Pfizer Non-oncology Biopharmaceuticals Product Offered

Table 68. Pfizer Main Business

Table 69. Pfizer Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Pfizer Latest Developments

Table 71. Novo Nordisk Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 72. Novo Nordisk Non-oncology Biopharmaceuticals Product Offered

Table 73. Novo Nordisk Main Business

Table 74. Novo Nordisk Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Novo Nordisk Latest Developments

Table 76. Novartis Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 77. Novartis Non-oncology Biopharmaceuticals Product Offered

Table 78. Novartis Main Business

Table 79. Novartis Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Novartis Latest Developments

Table 81. Merck Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 82. Merck Non-oncology Biopharmaceuticals Product Offered

Table 83. Merck Main Business

Table 84. Merck Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Merck Latest Developments

Table 86. Teva Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 87. Teva Non-oncology Biopharmaceuticals Product Offered

Table 88. Teva Main Business

Table 89. Teva Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Teva Latest Developments

Table 91. Eli Lilly Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 92. Eli Lilly Non-oncology Biopharmaceuticals Product Offered

Table 93. Eli Lilly Main Business

Table 94. Eli Lilly Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Eli Lilly Latest Developments

Table 96. Bristol-Myers Squibb Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 97. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Offered

Table 98. Bristol-Myers Squibb Main Business

Table 99. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Bristol-Myers Squibb Latest Developments

Table 101. GlaxoSmithKline Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 102. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Offered

Table 103. GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. GlaxoSmithKline Main Business

Table 105. GlaxoSmithKline Latest Developments

Table 106. UCB Pharma Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 107. UCB Pharma Non-oncology Biopharmaceuticals Product Offered

Table 108. UCB Pharma Main Business

Table 109. UCB Pharma Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. UCB Pharma Latest Developments

Table 111. Amgen Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 112. Amgen Non-oncology Biopharmaceuticals Product Offered

Table 113. Amgen Main Business

Table 114. Amgen Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Amgen Latest Developments

Table 116. AbbVie Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 117. AbbVie Non-oncology Biopharmaceuticals Product Offered

Table 118. AbbVie Main Business

Table 119. AbbVie Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. AbbVie Latest Developments

Table 121. Takeda Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 122. Takeda Non-oncology Biopharmaceuticals Product Offered

Table 123. Takeda Main Business

Table 124. Takeda Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Takeda Latest Developments

Table 126. AstraZeneca Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 127. AstraZeneca Non-oncology Biopharmaceuticals Product Offered

Table 128. AstraZeneca Main Business

Table 129. AstraZeneca Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. AstraZeneca Latest Developments

Table 131. Mylan Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 132. Mylan Non-oncology Biopharmaceuticals Product Offered

Table 133. Mylan Main Business

Table 134. Mylan Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Mylan Latest Developments

Table 136. LEO Pharma Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 137. LEO Pharma Non-oncology Biopharmaceuticals Product Offered

Table 138. LEO Pharma Main Business

Table 139. LEO Pharma Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. LEO Pharma Latest Developments

Table 141. Boehringer Ingelheim Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 142. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Offered

Table 143. Boehringer Ingelheim Main Business

Table 144. Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 145. Boehringer Ingelheim Latest Developments

Table 146. Alexion Pharmaceuticals Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 147. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Offered

Table 148. Alexion Pharmaceuticals Main Business

Table 149. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 150. Alexion Pharmaceuticals Latest Developments

Table 151. Elusys Therapeutics Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 152. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Offered

Table 153. Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 154. Elusys Therapeutics Main Business

Table 155. Elusys Therapeutics Latest Developments

Table 156. Swedish Orphan Biovitrum Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 157. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Offered

Table 158. Swedish Orphan Biovitrum Main Business

Table 159. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 160. Swedish Orphan Biovitrum Latest Developments

Table 161. Biogen Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors

Table 162. Biogen Non-oncology Biopharmaceuticals Product Offered

Table 163. Biogen Main Business

Table 164. Biogen Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 165. Biogen Latest Developments

List of Figures

Figure 1. Non-oncology Biopharmaceuticals Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Non-oncology Biopharmaceuticals Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 7. Non-oncology Biopharmaceuticals in Immunology

Figure 8. Global Non-oncology Biopharmaceuticals Market: Immunology (2017-2022) & ($ Millions)

Figure 9. Non-oncology Biopharmaceuticals in Endocrinology

Figure 10. Global Non-oncology Biopharmaceuticals Market: Endocrinology (2017-2022) & ($ Millions)

Figure 11. Non-oncology Biopharmaceuticals in Others

Figure 12. Global Non-oncology Biopharmaceuticals Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 14. Global Non-oncology Biopharmaceuticals Revenue Market Share by Player in 2021

Figure 15. Global Non-oncology Biopharmaceuticals Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 17. APAC Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 18. Europe Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 20. Americas Non-oncology Biopharmaceuticals Value Market Share by Country in 2021

Figure 21. Americas Non-oncology Biopharmaceuticals Consumption Market Share by Type in 2021

Figure 22. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 23. United States Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Region in 2021

Figure 28. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 29. China Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Country in 2021

Figure 36. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 37. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 38. Germany Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 46. Egypt Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 52. APAC Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 53. Europe Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 55. United States Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 56. Canada Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 59. China Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 60. Japan Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 61. Korea Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 63. India Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 64. Australia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 65. Germany Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 66. France Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 67. UK Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 68. Italy Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 69. Russia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 70. Spain Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 73. Israel Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)